http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101890423-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_20480c34cdf10fe8566594f4d9551fd8 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S514-822 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-81 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-81 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-105 |
| filingDate | 2017-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f17042495395a43e20d9455730d4358 |
| publicationDate | 2018-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101890423-B1 |
| titleOfInvention | Pharmaceutical composition comprising the extracts of eggplant as an effective component for prevention or treatment of thrombosis and health functional food comprising the same |
| abstract | The present invention relates to an antithrombotic composition containing an extract of Eggplant ( Solanum melongena L.) as an active ingredient, and more particularly, to an antithrombotic composition comprising an extract of eggplant and a tree nut obtained by heat treatment in a closed container at a high temperature for a long time A pharmaceutical composition for preventing or treating thrombosis, and a health functional food containing the ethyl acetate fraction as an active ingredient. The pharmaceutical composition for the prevention or treatment of thrombosis according to the present invention and the egg branch extract as an active ingredient of the health functional food can be used as an effective ingredient for the prevention and treatment of thrombosis due to the inhibition of the thrombogenic enzyme and the inhibition of the blood coagulation factor Exhibits antithrombotic activity, exhibits no hemolytic activity against human erythrocytes, exhibits excellent thermal stability, and does not exhibit the effect of inhibiting thrombogenesis-related enzymes and blood coagulation factors in acidic conditions of pH 2 and plasma, And is expected to be used for the prevention and treatment of thrombosis such as ischemic stroke and hemorrhagic stroke through the improvement of blood pressure and blood pressure. The active ingredient can be processed into various forms such as extract, powder, Can be very useful in the pharmaceutical industry and food industry Will. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110916103-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110916103-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102245405-B1 |
| priorityDate | 2017-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 128.